Two categories of compounds that are frequently confused despite being fundamentally different in chemistry, mechanism, risk profile and legal status. Here is what the research actually says.
This article is for general educational purposes only and does not constitute medical advice. Both anabolic steroids and therapeutic peptides in Australia require assessment by an AHPRA-registered medical practitioner before any prescription is appropriate. Always consult a qualified doctor before making any decisions about your health.
Peptides and steroids are frequently mentioned in the same conversations, particularly in fitness and performance contexts. Despite this, they are fundamentally different categories of compounds that work through completely different mechanisms, carry different risk profiles, and sit in different regulatory categories. Understanding the actual differences matters both for making informed decisions about health and for understanding why the two are not interchangeable.
This page covers what peptides and anabolic steroids actually are, how their mechanisms differ, what the evidence says about their respective risk profiles, and how their legal status compares in Australia.
Anabolic steroids are synthetic derivatives of testosterone. They work by binding to androgen receptors in cells throughout the body, including in muscle tissue, and activating gene expression that increases protein synthesis. This is how they produce their muscle-building and performance-enhancing effects. Because testosterone and its derivatives influence a wide range of biological processes, anabolic steroids affect multiple systems simultaneously, not just muscle tissue.
The systemic nature of anabolic steroid action is central to understanding their risk profile. Androgens regulate functions across the cardiovascular system, the liver, the reproductive system, the skin, and the hormonal feedback loops that govern the body's own testosterone production. Interfering with these systems broadly and simultaneously is associated with the well-documented adverse effects of anabolic steroid use, including cardiovascular changes, hepatic stress, hormonal disruption, and dermatological effects.
Anabolic steroids used without a medical purpose are classified as Schedule 4 controlled substances in Australia, and in some jurisdictions possession without a valid prescription carries specific legal penalties beyond those associated with other Schedule 4 medicines.
Peptides are short chains of amino acids that act as biological signalling molecules. Rather than directly replacing or supplementing a hormone the way anabolic steroids do with testosterone, peptides typically work by binding to specific receptors and triggering a downstream response in the body's own biological systems. The distinction is between directly imposing a hormonal state on the body versus signalling the body to respond in a particular way.
Different peptides target different receptors and different biological systems. Some interact with growth hormone pathways, some with tissue repair signalling, some with immune function, some with cardiovascular pathways. Because of this specificity, the biological effects of any given peptide tend to be more targeted than the broad systemic effects of anabolic steroids, though this varies between compounds and the research base for many peptides is still developing.
One of the most clinically significant differences between anabolic steroids and most therapeutic peptides is their relationship to the body's own hormonal production. Anabolic steroids, as synthetic androgens, trigger the body's hormonal feedback systems to reduce or stop producing its own testosterone, since the body detects high androgen levels and downregulates its own production accordingly. This is why steroid users often experience significant hormonal disruption when they stop using, and why post-cycle therapy has become a common practice in steroid use contexts.
Most therapeutic peptides, by contrast, work through different pathways that do not directly trigger this kind of feedback suppression of the body's own hormone production. Peptides that interact with growth hormone pathways, for example, signal the pituitary to release more of its own growth hormone rather than replacing growth hormone directly. This is a meaningfully different relationship with the body's own hormonal systems.
The adverse effect profile of anabolic steroids is well documented through decades of research and clinical observation. Cardiovascular effects, including changes to cholesterol ratios, left ventricular hypertrophy, and increased cardiovascular event risk, are among the most clinically significant. Hepatic stress, particularly with oral anabolic steroids, is well established. Reproductive effects, including testicular atrophy and reduced fertility, are associated with sustained use. Dermatological effects including acne are common.
The risk profile of therapeutic peptides is less comprehensively established, partly because the research base is less mature and partly because the compounds are significantly more varied. Research conducted in controlled settings with verified pharmaceutical-grade material generally shows a more favourable short-term tolerability profile than anabolic steroids, but long-term human safety data is more limited for many compounds. This is one of the genuine reasons medical supervision matters for peptide therapy.
Why the confusion exists: Peptides and steroids are sometimes discussed together because both categories have been used in performance and physique contexts, and both require a prescription in Australia. However, the similarity largely ends there. The mechanisms, risk profiles, effects on the body's own hormonal systems, and the quality and maturity of the research base are all significantly different between the two categories.
Both anabolic steroids and therapeutic peptides are Schedule 4 prescription-only medicines in Australia, meaning neither can be legally obtained without a valid prescription from an AHPRA-registered medical practitioner. In practice, anabolic steroids for non-medical purposes are rarely prescribed by Australian doctors, and obtaining them without a prescription carries significant legal risk.
Therapeutic peptides, by contrast, are prescribed for a range of legitimate health applications through specialist telehealth services operating within the proper regulatory framework, including UHD BioHealth. The pathway to legal access is clear and accessible in a way that anabolic steroids for non-medical use are not.
UHD BioHealth does not prescribe anabolic steroids. Our protocols involve therapeutic peptides prescribed by AHPRA-registered doctors following individual clinical assessments, dispensed through licensed Australian compounding pharmacies. The assessment process evaluates each individual's health history and circumstances to determine what is clinically appropriate for them specifically.
The assessment is free, there is no cost until you choose to proceed, and you receive a personalised protocol from a prescribing doctor that is specific to your situation rather than a generic approach.
Start with a free assessment. A doctor reviews your history and goals and builds a protocol around your specific situation if one is appropriate. No cost until you choose to proceed.